Route of Administration for UGN-101 and Impact on Oncological and Safety Outcomes.
Linehan J, Gottlieb J, Woldu SL, Labbate C, Rose K, Sexton W, Kaimakliotis H, Jacob J, Dickstein R, Nieder A, Bjurlin M, Humphreys M, Ghodoussipor S, Quek M, O'Donnell M, Eisner BH, Feldman AS, Matin SF, Lotan Y, Murray KS.
Linehan J, et al. Among authors: eisner bh.
Eur Urol Focus. 2023 Nov;9(6):1052-1058. doi: 10.1016/j.euf.2023.05.012. Epub 2023 May 30.
Eur Urol Focus. 2023.
PMID: 37263827